Parkinson’s disease is considered the second most common neurodegenerative disorder after Alzheimer’s.
The genetic predisposition is 5-10%
PD is one of the most common disorders, affecting 1-2 in 1,000 people.
This prevalence increases with age.In industrialized countries, the prevalence in the population oscillates between 0.3% and 1% in subjects over 60 years of age, and reaches 3% in those over 80 years of age.
The number of PD patients is expected to double by 2030.
MORBIDITY: According to the NECIDES (Neurological Disorders in Central Spain) study, it was observed that only 14.6% of patients with PD established the disease as the cause of death.
A therapeutic intervention that could prevent the misfolding of αSyn and its oligomerization into toxic species may reduce neurodegeneration, neuroinflammation and the consequent disease propagation.
This prevalence increases with age.In industrialized countries, the prevalence in the population oscillates between 0.3% and 1% in subjects over 60 years of age, and reaches 3% in those over 80 years of age.
The number of PD patients is expected to double by 2030.
MORBIDITY: According to the NECIDES (Neurological Disorders in Central Spain) study, it was observed that only 14.6% of patients with PD established the disease as the cause of death.
Email: mcarrion@cajal.csic.es
Avenida del Dr. Arce, 37, 28002 Madrid
Dont like Filling up forms ? Mail us then
Avenida del Dr. Arce, 37, 28002 Madrid
